{
    "Trade/Device Name(s)": [
        "FIRST RESPONSE\u2122 Gold\u2122 Digital Pregnancy Test"
    ],
    "Submitter Information": "Church & Dwight Co., Inc.",
    "510(k) Number": "K123567",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083716"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "September 10, 2013",
    "Summary Letter Received Date": "September 4, 2013",
    "Submission Date": "September 3, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (hCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)",
        "hCG beta core fragment (hCG \u03b2cf)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Plastic cup (for urine collection)"
    ],
    "Instrument(s)/Platform(s)": [
        "FIRST RESPONSE\u2122 Gold\u2122 Digital Pregnancy Test device (includes chromatographic strip and digital display)"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Immunochemical reaction"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for FIRST RESPONSE\u2122 Gold\u2122 Digital Pregnancy Test, a qualitative chromatographic immunoassay for early pregnancy detection in urine with digital result display.",
    "Indications for Use Summary": "Over-the-counter qualitative chromatographic immunoassay for detection of hCG in urine, intended for early pregnancy detection as early as six days before missed period.",
    "fda_folder": "Clinical Chemistry"
}